MedPath

Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability

Not Applicable
Completed
Conditions
HPV Vaccine Acceptability
Interventions
Other: Adolescents and parents' education and motivation at school (component 1)
Other: General practitioners' training (component 2)
Other: Access to vaccination at school (component 3)
Registration Number
NCT04945655
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Brief Summary

This study aims at evaluating the effectiveness, efficiency and implementation of a multicomponent intervention (components being applied in combination or alone) on the acceptability of HPV vaccine among French adolescents (11-14 years old) through a cluster randomized controlled trial. The primary outcome to measure acceptability is vaccine coverage. The three components are: adolescents and parents' education and motivation at school (component 1); general practitioners' training (component 2); and access to vaccination at school (component 3). Ninety municipalities are included and randomized into six groups of 15 municipalities, according an incomplete factorial plan.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30739
Inclusion Criteria
  • Adolescents (school years 9-10), and parents of adolescents (school years 7-10) attending secondary schools in the participating municipalities.
Exclusion Criteria
  • /

General practitioners' training (component 2) and "KABP-6C" survey among general practitioners (arms 1, 2 and 5)

Inclusion Criteria:

  • General practitioners' practicing in the participating municipalities.

Exclusion Criteria:

  • Exclusive particular type of practice.
  • Planning to retire or move their practice within the study period.
  • No internet access.

Access to vaccination at school (component 3 -- arms 1 and 3)

Inclusion Criteria:

  • Adolescents (school years 7-10) attending secondary schools in the participating municipalities, aged 11-14 years (with a possible catch-up for those aged 15-19 years according to the French recommendations).

Exclusion Criteria:

  • Having initiated HPV vaccination.
  • No written consent from parents/caregivers for vaccination.
  • Contraindication to HPV vaccination.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Arm 2: component 1 + component 2General practitioners' training (component 2)Adolescents and parents' education and motivation at school (component 1) + General practitioners' training (component 2)
Arm 3: component 1 + component 3Access to vaccination at school (component 3)Adolescents and parents' education and motivation at school (component 1) + Access to vaccination at school (component 3)
Arm 1: component 1 + component 2 + component 3Access to vaccination at school (component 3)Adolescents and parents' education and motivation at school (component 1) + General practitioners' training (component 2) + Access to vaccination at school (component 3)
Arm 1: component 1 + component 2 + component 3General practitioners' training (component 2)Adolescents and parents' education and motivation at school (component 1) + General practitioners' training (component 2) + Access to vaccination at school (component 3)
Arm 2: component 1 + component 2Adolescents and parents' education and motivation at school (component 1)Adolescents and parents' education and motivation at school (component 1) + General practitioners' training (component 2)
Arm 3: component 1 + component 3Adolescents and parents' education and motivation at school (component 1)Adolescents and parents' education and motivation at school (component 1) + Access to vaccination at school (component 3)
Arm 1: component 1 + component 2 + component 3Adolescents and parents' education and motivation at school (component 1)Adolescents and parents' education and motivation at school (component 1) + General practitioners' training (component 2) + Access to vaccination at school (component 3)
Arm 4: component 1Adolescents and parents' education and motivation at school (component 1)Adolescents and parents' education and motivation at school (component 1)
Arm 5: component 2General practitioners' training (component 2)General practitioners' training (component 2)
Primary Outcome Measures
NameTimeMethod
HPV vaccine coverage (≥ 1 dose)2 months after intervention

Percentage of adolescents aged 11-14 years, living in the municipality, who have received at least one dose of HPV vaccine

Secondary Outcome Measures
NameTimeMethod
HPV vaccine coverage (≥ 1 dose)6 months and 12 months after intervention

Percentage of adolescents aged 11-14 years, living in the municipality, who have received at least one dose of HPV vaccine

HPV vaccine coverage (2 doses)2 months, 6 months and 12 months after intervention

Percentage of adolescents aged 11-14 years, living in the municipality, who have received two doses of HPV vaccine

HPV vaccination intentionBefore intervention and 2 months after intervention

Percentage of each group of participants (adolescents, parents and general practitioners) who have the intention to initiate/have their child vaccinated/recommend HPV vaccination

Intervention components' adaptationIntervention components' implementation period

Number of activities performed which have been modified to adapt them to the local context / total number of activities performed. A description of the adaptations performed will be provided. Data come from regular activity reports collected on a standardised form during components' implementation.

Satisfaction of target populations about the activities / tools, assessed by a 4-point Likert scaleEnd of the intervention components' implementation period

Percentage of target individuals (adolescents, parents and general practitioners) who declare to be satisfied with each activity / tool (e.g., satisfaction of adolescents and school staff about the vaccination day organized inside the school premises, satisfaction of general practitioners about the e-learning training session). Satisfaction will be collected using self-administered (paper or online) questionnaires.

Knowledge, attitude, beliefs and practices towards HPV vaccination and psychological determinants of vaccination intention ("KABP-6C")Before intervention and 2 months after intervention

Each group participants' (adolescents, parents and general practitioners) knowledge and attitude towards HPV vaccination will be assessed for each of the " 6-C " components (Confidence, Complacency, Constraints, Calculation, Collective responsibility and social Conformism). Following results from otherwise onging research on psychological antecedents of vaccination, a 7 th C has been identified, refering to Confidence in the system (including reactance). The 6C thus has been extended to a 7C scale.

In addition to analysis of individual items, a score of knowledge (from 0 - poor knowledge -- to 12 -- good knowledge) and a score of attitude (from 0 - unfavourable attitude -- to 24 - very favourable attitude) will then be calculated. Practices towards HPV vaccination (self-declared vaccination status / recommendation to patients) will be assessed using closed questions. Data will be collected using ad hoc self-administered online KABP-7C questionnaires.

Incremental Cost-Effectiveness Ratio2 months after intervention

Incremental Cost-Effectiveness Ratio

Reached populationsIntervention components' implementation period

Percentage of target individuals who benefit from (or participate in) activities of each component (assessment of the acceptability of each component)

Intervention components' dose and fidelityIntervention components' implementation period

Number of different activities really performed for each component / number of activities planned for each component according to the protocol. Data come from regular activity reports collected on a standardised form during components' implementation.

Trial Locations

Locations (1)

Secondary schools and GPs' practices of the participating municipalities

🇫🇷

Participating Municipalities, France

© Copyright 2025. All Rights Reserved by MedPath